Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: A systematic review

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 116, Issue 2, 2009, Pages 137-143

  Atiomo, W ^a,c   Khalid, S ^a   Parameshweran, S ^b   Houda, M ^b   Layfield, R ^c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

2D DIGE; 2DE; Biomarker; MALDI TOF; Ovary; PCOS; Polycystic; Proteomic; RP SPE; SELDI; Syndrome

Indexed keywords

BIOLOGICAL MARKER; COFILIN 1; COMPLEMENT COMPONENT C4A; F ACTIN; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE ALPHA; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANOSINE DIPHOSPHATE; HEAT SHOCK PROTEIN 27; HOMOCYSTEINE; LEUKOTRIENE; LIPOCORTIN 5; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROGESTERONE; PROSTAGLANDIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; TESTOSTERONE;

ANGIOGENESIS; APOPTOSIS; CHOLESTEROL TRANSPORT; COLLAGEN METABOLISM; CYTOSKELETON; DATA BASE; DNA DAMAGE; ELECTROPHORESIS; EMBASE; FIBRINOLYSIS; GLUCOSE METABOLISM; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MASS SPECTROMETER; MEDLINE; METABOLISM; OVARY FOLLICLE; OVARY FOLLICLE FLUID; OVARY POLYCYSTIC DISEASE; PERITONEAL BIOPSY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; PROTEOMICS; REVERSED PHASE LIQUID CHROMATOGRAPHY; REVIEW; SERUM; SYSTEMATIC REVIEW; T LYMPHOCYTE; THROMBOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BIOLOGICAL MARKERS; FEMALE; FOLLICULAR FLUID; HUMANS; OMENTUM; OVARY; POLYCYSTIC OVARY SYNDROME; PROTEOMICS; T-LYMPHOCYTES;

EID: 57449107395     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2008.02041.x     Document Type: Review

References (43)

1. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991 338 : 131.
2. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2002 CD000065.
3. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to PCOS. Fertil Steril 2004 81 : 19 25.
4. Azziz R, Marin C, Hoq L, Badamgarav E, Song P. Health care-related economic burden of the PCOS during the reproductive life span. J Clin Endocrinol Metab 2005 90 : 4650 8.
5. Cussons AJ, Stuckey BG, Walsh JP, Burke V, Norman RJ. Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management. Clin Endocrinol (Oxf) 2005 62 : 289 95.
6. Martin R. A plea for 'Omics' research in complex disease such as multiple sclerosis - a change of mind is needed. J Neurol Sci 2004 222 : 3 5.
7. Coca SG, Yalavarthy R, Concato J, Parikh CR. Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 2008 73 : 1008 16.
8. Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzschmar HA, et al. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996 348 : 846 9.
9. Borro M, Gentile G, Stigliano A, Misiti S, Toscano V, Simmaco M. Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases. Clin Exp Immunol 2007 150 : 494 501.
10. Choi BC, Kim YS, Kim MS, Chung MK, Choi CH, Baek KH. Identification of overexpressed proteins by proteomic analysis using human follicular fluids derived from polycystic ovary syndrome (PCOS) patients. Fertil Steril 2007 88 : S180.
11. Corton M, Botella-Carretero JI, Lopez JA, Camafeita E, San Millán JL, Escobar-Morreale HF, et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod 2008 23 : 651 61.
12. Ma X, Fan L, Meng Y, Hou Z, Mao YD, Wang W, Ding W, Liu JY. Differential Expression Of Proteins Of Human Ovaries From Normal And Polycystic Ovarian Syndrome By 2-Dimensional Gel Electrophoresis/Mass Spectrometry Analysis. Progress On Post-Genome Technologies. Nanjing : Phoenix Publ & Media Network, 2007.
13. Ma X, Fan L, Meng Y, Hou Z, Mao YD, Wang W, et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. Mol Hum Reprod 2007 13 : 527 35.
14. Matharoo-Ball B, Hughes C, Lancashire L, Tooth D, Ball G, Creaser C, et al. Characterization of biomarkers in PCOS using multiple distinct proteomic platforms. J Proteome Res 2007 6 : 3321 8.
15. Zhao S-Y, Qiao J, Li M-Z, Zhang X-W, Yu J-K, Li R. Preliminary study of protein expression profiling of PCOS on different state. Zhonghua Yi Xue Za Zhi 2008 88 : 7 11.
16. Zhao SY, Qiao J, Li MZ, Zhang X, Yu J, Li R. Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry. Fertil Steril 2007 88 : 145 51.
17. Zhao SY, Qiao J, Li MZ. Protein expression profilings of polycystic ovary syndrome. Beijing Da Xue Xue Bao 2005 37 : 362 5.
18. Hughes C, Elgasim M, Layfield R, Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome - progress so far: mini review. Hum Reprod 2006 21 : 2766 75.
19. Escobar-Morreale H, Insenser M, Corton M, San Millán JL, Peral B. Proteomics and genomics: a hypothesis-free approach to the study of the role of visceral adiposity in the pathogenesis of the polycystic ovary syndrome. Proteomics Clin Appl 2008 2 : 444 55.
20. Escobar-Morreale H, Luque-Ramirez M, San Millan J. The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome. Endocr Rev 2005 26 : 251 82.
21. Escobar-Morreale HF, Millan JLS. Abdominal adiposity and the polycystic ovary syndrome. Trends in Endocrinology and Metabolism 2007 18 : 266 72.
22. Phillips KP, Foster WG. Key developments in endocrine disrupter research and human health. J Toxicol Environ Health B Crit Rev 2008 11 : 322 44.
23. Sharma A, Atiomo W. Recent developments in polycystic ovary syndrome. Curr Obstet Gynaecol 2003 13 : 281 6.
24. Corton M, Villuendas G, Botella JI, San Millán JL, Escobar-Morreale HF, Peral B. Improved resolution of the human adipose tissue proteome at alkaline and wide range pH by the addition of hydroxyethyl disulfide. Proteomics 2004 4 : 438 41.
25. Wang L, Zhu YF, Guo XJ, Huo R, Ma X, Lin M, et al. A two-dimensional electrophoresis reference map of human ovary. J Mol Med 2005 83 : 812 21.
26. Wikipedia. Mass spectrometry. 2008 http://en.wikipedia.org/wiki/ Mass_spectrometry Accessed 15 September 2008.
27. Wikipedia. Proteomics. 2008 http://en.wikipedia.org/wiki/Proteomics Accessed 15 September 2008.
28. Chuthapisith S, Layfield R, Kerr ID, Eremin O. Principles of proteomics and its applications in cancer. Surgeon 2007 5 : 14 22.
29. Tsilchorozidou T, Overton C, Conway GS. The pathophysiology of polycystic ovary syndrome. Clin Endocrinol (Oxf) 2004 60 : 1 17.
30. Zhang D, Luo WY, Liao H, Wang CF, Sun Y The effects of oxidative stress to PCOS Sichuan Da Xue Xue Bao Yi Xue Ban 2008 39 : 421 3.
31. Fenkci V, Fenkci S, Yilmazer M, Serteser M. Decreased total antioxidant status and increased oxidative stress in women with polycystic ovary syndrome may contribute to the risk of cardiovascular disease. Fertil Steril 2003 80 : 123 7.
32. Sabuncu T, Vural H, Harma M, Harma M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem 2001 34 : 407 13.
33. Hoeger KM, Kochman L, Wixom N, Craig K, Miller RK, Guzick DS. A randomized 48-week, placebo controlled trial of intensive lifestyle modification and/or metformin therapy in overweight women with polycystic ovary syndrome: a pilot study. Fertil Steril 2004 82 : 421 9.
34. Moll E, Bossuyt PM, Korevaar JC, Lambalk CB, van der Veen F. Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial. BMJ 2006 332 : 1485.
35. Puder JJ, Varga S, Kraenzlin M, De Geyter C, Keller U, Muller B. Central fat excess in PCOS: relation to low-grade inflammation and insulin resistance. J Clin Endocrinol Metab 2005 90 : 6014 21.
36. Meek SC, Hodge DD, Musich JR. Autoimmunity in infertile patients with endometriosis. Am J Obstet Gynecol 1988 158 : 1365 73.
37. Yang Y, Chung EK, Zhou B, Lhotta K, Hebert LA, Birmingham DJ, et al. The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun 2004 7 : 98 132.
38. Onat A, Uzunlar B, Hergenc G, Yazici M, Sari I, Uyarel H, et al. Cross-sectional study of complement C3 as a coronary risk factor among men and women. Clin Sci (Lond) 2005 108 : 129 35.
39. Zhang R, Barker L, Pinchev D, Marshall J, Rasamoelisolo M, Smith C, et al. Mining biomarkers in human sera using proteomic tools. Proteomics 2004 4 : 244 56.
40. Mischak H, Apweiler R, Banks RE, Conaway M, Coon J, Dominiczak A, et al. Clinical proteomics: a need to define the field and to begin to set adequate standards. Proteomics Clin Appl 2007 1 : 148 56.
41. Zintzaras E, Ioannidis JP. Meta-analysis for ranked discovery datasets: theoretical framework and empirical demonstration for microarrays. Comput Biol Chem 2008 32 : 39 47.
42. Price MJ. The LHC project. Nucl Instrum Meth A 2002 478 : 46 61.
43. Guterl F, Underhill W, Gardland S. Land of big science. Newsweek 2008 15 : 42 3.